Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

v3.22.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ 9,222,780 $ (4,461,996)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Income from investments held in Trust Account (33,789) (3,388)
Change in fair value of derivative warrant liabilities (9,603,800) 3,305,000
Financing cost - derivative warrant liabilities   821,170
Changes in operating assets and liabilities:    
Prepaid expenses (427) (540,441)
Accounts payable 135,135 223,322
Accounts payable - related party 45,000 30,000
Accrued expenses (74,224) 14,358
Net cash used in operating activities (309,325) (611,975)
Cash Flows from Investing Activities:    
Cash deposited in Trust Account (414,000,000.0) (414,000,000)
Net cash used in investing activities   (414,000,000)
Cash Flows from Financing Activities:    
Proceeds received from initial public offering, gross   414,000,000
Proceeds from private placement   10,280,000
Repayment of notes payable to related party   (185,116)
Offering costs paid   (8,715,099)
Net cash provided by financing activities   415,379,785
Net change in cash (309,325) 767,810
Cash - beginning of the period 399,935 6,410
Cash - end of the period $ 90,610 774,220
Supplemental disclosure of noncash investing and financing activities:    
Offering costs included in accrued expenses   85,000
Offering costs included in notes payable   45,167
Deferred underwriting commissions in connection with the initial public offering   $ 14,490,000